ProPhase Labs, Inc. (NASDAQ:PRPH) filed a Form 8-K with the Securities and Exchange Commission on February 13, 2026, disclosing a material event.
ProPhase Labs, Inc.'s stock currently trades at $0.15 with a market capitalization of $6.3M. The Healthcare company's stock moved following the disclosure.